EGFR/PI3K/AKT信号通路在肺癌中的研究进展

被引：12

作者：

王娜 ^{[1
]}

栾材富 ^{[2
]}

机构：

[1] 青岛大学

[2] 青岛大学医学院附属烟台毓璜顶医院

来源：

国际检验医学杂志 | 2016年 / 37卷 / 14期

关键词：

表皮生长因子受体; 磷脂酰肌醇-3激酶; AKT; 肺癌; 靶向治疗;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

<正>肺癌是临床最常见的恶性肿瘤之一,为我国城市肿瘤相关死亡的主要病因,近年来肺癌的发病率和病死率增长迅速,严重危害人类健康和生命。在我国,每年大约有30万人被诊断患有肺癌,超过25万人因该病死亡[1]。肺癌从组织学上分为小细胞型肺癌和非小细胞型肺癌（NSCLC）,其中NSCLC占

引用

页码：1984 / 1987

页数：4

共 12 条

[1]

Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling [J].

Zhong, Daixing ;

Ru, Yi ;

Wang, Qinhao ;

Zhang, Jing ;

Zhang, Jian ;

Wei, Junxia ;

Wu, Jin ;

Yao, Libo ;

Li, Xiaofei ;

Li, Xia .

CANCER LETTERS, 2015, 359 (01) :57-64

[2]

MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.[J].Jun Pei;Yuqing Lou;Runbo Zhong;Baohui Han.Tumor Biology.2014, 7

[3]

MicroRNA-34a overcomes HGF-mediated gefitinib resistance in EGFR mutant lung cancer cells partly by targeting MET [J].

Zhou, Jian-Ya ;

Chen, Xi ;

Zhao, Jing ;

Bao, Zhang ;

Chen, Xing ;

Zhang, Pei ;

Liu, Zhen-Feng ;

Zhou, Jian-Ying .

CANCER LETTERS, 2014, 351 (02) :265-271

[4]

Combination of BIB W2992 and ARQ 197 is effective against erlotinib-resistant human lung cancer cells with the EGFR T790M mutation [J].

Qu, Geping ;

Liu, Changting ;

Sun, Baojun ;

Zhou, Changxi ;

Zhang, Zhijian ;

Wang, Peng .

ONCOLOGY REPORTS, 2014, 32 (01) :341-347

[5]

Genes and Pathology of Non-Small Cell Lung Carcinoma [J].

Sakashita, Shingo ;

Sakashita, Mai ;

Tsao, Ming Sound .

SEMINARS IN ONCOLOGY, 2014, 41 (01) :28-39

[6]

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC) [J].

Kobayashi, Kunihiko ;

Hagiwara, Koichi .

TARGETED ONCOLOGY, 2013, 8 (01) :27-33

[7]

Dual Inhibition of Met Kinase and Angiogenesis to Overcome HGF-Induced EGFR-TKI Resistance in EGFR Mutant Lung Cancer [J].

Takeuchi, Shinji ;

Wang, Wei ;

Li, Qi ;

Yamada, Tadaaki ;

Kita, Kenji ;

Donev, Ivan S. ;

Nakamura, Takahiro ;

Matsumoto, Kunio ;

Shimizu, Eiji ;

Nishioka, Yasuhiko ;

Sone, Saburo ;

Nakagawa, Takayuki ;

Uenaka, Toshimitsu ;

Yano, Seiji .

AMERICAN JOURNAL OF PATHOLOGY, 2012, 181 (03) :1034-1043

[8]

Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis [J].

Lin, F. ;

Lin, P. ;

Zhao, D. ;

Chen, Y. ;

Xiao, L. ;

Qin, W. ;

Li, D. ;

Chen, H. ;

Zhao, B. ;

Zou, H. ;

Zheng, X. ;

Yu, X. .

CELL PROLIFERATION, 2012, 45 (03) :207-216

[9]

Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome Gefitinib-resistance in non-small cell lung cancer cell lines [J].

Li, H. ;

Schmid-Bindert, G. ;

Wang, D. ;

Zhao, Y. ;

Yang, X. ;

Su, B. ;

Zhou, C. .

ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02) :275-284

[10]

EGFR Mutations and Lung Cancer.[J].Gilda da Cunha Santos;Frances A. Shepherd;Ming Sound Tsao.Annual Review of Pathology: Mechanisms of Disease.2011, 1

← 1 2 →